Cargando…
Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study
BACKGROUND: The optimal locoregional treatment for hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT) is unclear. This study aimed to investigate the efficacy of Gamma knife radiosurgery (GKR) versus transcatheter arterial chemoembolization (TACE) in HCC patients with PVT...
Autores principales: | Su, Ke, Gu, Tao, Xu, Ke, Wang, Jing, Liao, Hongfei, Li, Xueting, Wen, Lianbin, Song, Yanqiong, Zhong, Jiaqi, He, Bingsheng, Liu, Xin, He, Jie, Liu, Yanlin, Li, Qi, Feng, Xunjie, Chen, Siyu, Yang, Binbin, Huang, Weihong, Jin, Hongping, Luo, Xiaotong, Hu, Teng, Chen, Jiali, Wu, Zhenying, Lu, Simin, Zhang, Jianwen, Rao, Mingyue, Xie, Yunchuan, Zhu, Xiaoning, Chen, Lan, Li, Bo, Su, Song, Yang, Xiaoli, Wang, Juan, Zeng, Hao, Wang, Pan, Yan, Min, Chen, Xiaojing, He, Kun, Han, Yunwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349123/ https://www.ncbi.nlm.nih.gov/pubmed/35729469 http://dx.doi.org/10.1007/s12072-022-10339-2 |
Ejemplares similares
-
Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (≥ 5 cm): a multicenter experience over a ten-year period
por: Su, Ke, et al.
Publicado: (2023) -
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study
por: Su, Ke, et al.
Publicado: (2022) -
Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis
por: Liu, Xin, et al.
Publicado: (2023) -
A propensity score matching study on survival benefits of radiotherapy in patients with inoperable hepatocellular carcinoma
por: Zeng, Hao, et al.
Publicado: (2023) -
PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis
por: Li, Han, et al.
Publicado: (2023)